NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

50 hedge funds and large institutions have $51M invested in NeuBase Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$3.68M
2 -$2.58M
3 -$756K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$216K
5
BlackRock
BlackRock
New York
-$200K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$15.4M
2
$6.96M
3
$6.88M
4
$4.23M
5
$2.31M
6
$2.11M
7
$1.81M
8
$1.48M
9
$1.14M
10
$1.13M
11
$1.1M
12
$733K
13
$694K
14
$658K
15
$415K
16
$391K
17
$324K
18
$313K
19
$262K
20
$229K
21
$203K
22
$198K
23
$154K
24
$153K
25
$152K